Avsnittsbeskrivning
Hunt, Jason, and Mike work through an oil market frozen by the US-Iran standoff, then spend the back half stress-testing SpaceX’s ~$2 trillion valuation against Tesla’s — landing on data centers in orbit and a chronic compute shortage as the load-bearing assumptions. Plus Apple’s WWDC miss, the software disruption map, and a strong week of healthcare data.
The Cashflow Memo
Key Takeaways
* Hunt’s working case: if the US-Iran standoff just persists, oil sits near $90 twelve months out despite deep backwardation (mid-$90s spot vs mid-$70s forward); the casualty is natural gas, because roughly two-thirds of dry-gas supply growth is Permian associated gas, so a higher oil price pumps more gas and keeps gas pricing weak.
* Exhibit A is the macro tail risk: holding public-debt-to-GNP under 100% requires keeping the deficit flat-to-declining near $1.5T even with higher defense spend — a developed-world problem (Japan is ~180%), not just a US one, and the thing that most threatens the credit markets.
* SpaceX’s ~$2T valuation only pencils on space-based data centers: 150kW micro-satellites (one NVL72-rack equivalent, Nvidia silicon, in-sourced solar), a ~1 GW launch cadence targeted by year-end, ~170 Starship launches per gigawatt (a launch every other day) off a 20-30 ship fleet. At ~$20B FCF per deployed gigawatt, ~$100B FCF — a 5% cash yield — looks more reachable for SpaceX than for Tesla at $1.4T, which needs robotaxi plus humanoids to get there.
* Compute scarcity is the load-bearing assumption under both bets: xAI’s ~$20B Colossus buildout in Memphis is already leasing capacity to Anthropic and Google at ~$25B of revenue — a near one-year payback that shows how acute the shortage is. The safer, cheaper derivative on chronic compute shortage remains Nvidia.
* AI has collapsed the cost to write software but not to support or design it: as the agent becomes the hub, Apple looks exposed (a second straight underwhelming Siri at WWDC, starting to look like IBM or Intel), while horizontal incumbents like Salesforce and ServiceNow can expand share and consumption-priced models gain over seat-based ones. In healthcare, Lilly’s triple-agonist retatrutide showed dramatic weight loss with less muscle loss, plus a gene-therapy LDL result, and Revolution Medicines tripled survival duration in pancreatic cancer by hitting targets long thought undruggable.
Show Notes
[00:00] Intro: The Cash Flow Memo Mike opens the weekly walk through energy, technology, and healthcare. Download the memo at telltales.us.
[00:52] Oil, Iran, and Why Gas Stays Weak With supply off ~2.5-3M bbl/d and the Iran embargo likely to persist, Hunt sees oil near $90 a year out despite heavy backwardation — and natural gas as the casualty, since Permian associated gas grows with oil.
[04:24] Exhibit A: The Deficit and the Credit Markets Keeping public-debt-to-GNP under 100% means holding the deficit near $1.5T even with higher defense spend. A developed-world problem, not just a US…
Webbplats: telltales.substack.com

